Follow
Matthew Davis
Matthew Davis
Principal, Medicus Economics
Verified email at medicuseconomics.com - Homepage
Title
Cited by
Cited by
Year
The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US
JI Ivanova, HG Birnbaum, S Samuels, M Davis, AL Phillips, D Meletiche
Pharmacoeconomics 27 (8), 681-691, 2009
852009
Estimating Alzheimer's disease progression rates from normal cognition through mild cognitive impairment and stages of dementia
M Davis, T O'Connell, S Johnson, S Cline, E Merikle, F Martenyi, ...
Current Alzheimer Research 15 (8), 777-788, 2018
732018
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis …
DT Rubin, M Mittal, M Davis, S Johnson, J Chao, M Skup
Journal of Managed Care & Specialty Pharmacy, 2017
622017
Direct costs and survival of medicare beneficiaries with early and advanced Parkinson’s disease
A Kaltenboeck, SJ Johnson, MR Davis, HG Birnbaum, CA Carroll, ...
Parkinsonism & related disorders 18 (4), 321-326, 2012
542012
Risk of developing comorbidities among women with endometriosis: a retrospective matched cohort study
ES Surrey, AM Soliman, SJ Johnson, M Davis, J Castelli-Haley, ...
Journal of women's health 27 (9), 1114-1123, 2018
502018
Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple …
S Yermakov, M Davis, M Calnan, M Fay, B Cox-Buckley, S Sarda, MS Duh, ...
Journal of medical economics 18 (9), 711-720, 2015
462015
Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids
MR Davis, AM Soliman, J Castelli-Haley, MC Snabes, ES Surrey
Journal of Women's Health 27 (10), 1204-1214, 2018
332018
Early retirement and income loss in patients with early and advanced Parkinson’s disease
S Johnson, M Davis, A Kaltenboeck, H Birnbaum, EB Grubb, M Tarrants, ...
Applied Health Economics and Health Policy 9 (6), 367-376, 2011
322011
Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA
DS Chu, SJ Johnson, UG Mallya, MR Davis, RA Sorg, MS Duh
Journal of ophthalmic inflammation and infection 3 (1), 1-10, 2013
312013
Patient support program increased medication adherence with lower total health care costs despite increased drug spending
D Brixner, DT Rubin, P Mease, M Mittal, H Liu, M Davis, A Ganguli, ...
Journal of Managed Care & Specialty Pharmacy 25 (7), 770-779, 2019
302019
Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs
HG Birnbaum, JI Ivanova, S Samuels, M Davis, PY Cremieux, AL Phillips, ...
Current medical research and opinion 25 (4), 869-877, 2009
272009
Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors
A Gibofsky, M Skup, M Mittal, SJ Johnson, M Davis, J Chao, DT Rubin
Current medical research and opinion 33 (11), 1945-1953, 2017
142017
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population
D Brixner, M Mittal, DT Rubin, P Mease, HH Liu, M Davis, A Ganguli, ...
Patient preference and adherence 13, 1545, 2019
102019
Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance
M Calnan, G Krishnarajah, MS Duh, BA Haider, S Yermakov, M Davis, ...
Human Vaccines & Immunotherapeutics 12 (5), 1235-1243, 2016
102016
Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS)
L Huynh, S Yermakov, M Davis, R Campbell, M Cleveland, FA Farraye, ...
Journal of Medical Economics 19 (4), 356-363, 2016
92016
Changes in healthcare spending after diagnosis of comorbidities among endometriosis patients: A difference-in-differences analysis
AJ Epstein, AM Soliman, M Davis, SJ Johnson, MC Snabes, ES Surrey
Advances in therapy 34 (11), 2491-2502, 2017
82017
Impact of Abbvie's Patient Support Program on Resource Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing …
DT Rubin, M Skup, M Davis, S Johnson, J Chao
Arthritis & Rheumatology 67, 2820-2821, 2015
82015
Percutaneous endoscopic gastrostomy (PEG) tubes for enteral nutrition support (ENS) in neurologically impaired children
S Bachrach, JO Melnychuk, NE Vinton, M Davis, S Shaffer, D Mehta
Dev Med Child Neurol (AACPDM Abstracts) 40, 16, 1998
81998
Bot detection: Will focusing on recall cause overall performance deterioration?
T H Nazer, M Davis, M Karami, L Akoglu, D Koelle, H Liu
International Conference on Social Computing, Behavioral-Cultural Modeling …, 2019
62019
Impact of early initiation of eslicarbazepine acetate on economic outcomes among patients with focal seizure: results from retrospective database analyses
D Mehta, M Davis, AJ Epstein, B Wensel, T Grinnell, GR Williams
Neurology and therapy 9 (2), 585-598, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20